Report: Pfizer to sell NYC HQ building

NEW YORK Pfizer is selling one of its New York properties to financial services firm TIAA-CREF, according to published reports.

Bloomberg reported that the drug maker would sell the skyscraper at 685 Third Ave. in New York for between $180 million and $190 million, quoting people familiar with the situation.

The sale reportedly is part of an effort to scale down operations following last year’s acquisition of drug maker Wyeth.

Login or Register to post a comment.